Sexism in Venture Capital: Why 'Penis' Is OK, But 'Vagina' Is Taboo
Sergei Polevikov, ABD, MBA, MS, MA ????????
Author of 'Advancing AI in Healthcare' | Healthcare AI Fraud Investigator
You can say "penis" at a VC pitch, but don't even think about saying "vagina." Female founders are "advised" to strike a more "neutral" tone, according to startling new research.
This is Part 1 of an infinite series on empirical analysis proving that venture capital is a scam, especially in healthcare, and why alternative, more optimal, and better-aligned approaches to asset allocation and investment in innovative startups are needed.
Today, millions of Americans are voting, with women’s rights and health squarely on the ballot. Yet, in the “VC bros” world, women’s progress is a rounding error.
In femtech—a sector supposedly focused on women’s needs—male founders are statistically more likely to get funded than female founders, often with half the merit.
In the world of the so-called “VC bros,” merit never even makes it to the ballot. And I’ve got the numbers to back that up.
In this article, I lay out the facts and opinions on why women VCs and founders are marginalized by “VC bros.” With a focus on femtech, I also spotlight a few hard-won victories along the way.
Forget DEI. Forget racial bias. Forget inequality. I’m talking about plain, unfiltered merit in venture capital. And here’s the brutal truth: there is none. Men are, on average, worse VC investors than women. Yet, according to recent research, they consistently receive more capital—even in femtech. It’s unbelievable. This is sexism in its rawest form, a disgrace that shouldn’t exist in today’s world.
I have two daughters. I just voted for their future—a future of equal rights and merit, where hard work and excellence are rewarded, regardless of gender, background, nationality, or anything else.
Here’s the TL;DR:
1. Naked Facts
2. Women’s Healthtech Startups Are Less Likely to Get Funding with Female Founders, according to The Guardian
2.1 The Barriers to Femtech Funding
2.2 The Funding Gender Gap in Femtech
2.3 The Exclusive VC Bro Club
2.4 Flo Health: A Case of Success and Industry Double Standards
2.5 Challenges Beyond Funding: Systemic Gender Bias in Distribution and Marketing
2.6 “Solution”: “Watch Your Language, Ladies!”
2.7 Small Steps Toward Progress and Accountability, and the Rise of Femtech Support
2.8 References
3. VCs Prefer White Male-Led Startups, according to PlanBeyond Study
领英推荐
4. Breaking Barriers: Women and Non-Binary Investors Reshaping Venture Capital
4.1 The Rise of Women-Led VC Funds
4.2 The Numbers Speak: Women VCs Produce Higher Returns, Faster Exits
4.3 Expanding DEI’s Reach Amid Backlash
4.4 Championing Diversity: Women and Non-Binary Leaders in High-Profile Sectors Like AI
4.5 Empowering Women Through Sustainable Capital Expansion
4.6 References
5. Small Investment Victories in Women's Health and Femtech
5.1 The Rise of Flo: The New Unicorn Innovating in Women’s Health
5.2 Beyond Flo: The New Wave of Femtech Champions Attracts Major Funding
5.3 Femtech: Skyrocketing Valuations and the Road Ahead
6. Why is it Still So Hard to Succeed in Women's Health and Femtech?
6.1 Capital Starvation and Risk Perception
6.2 Visibility and Representation
6.3 Social Taboos and the "Yuck Factor"
6.4 The TAM Problem: Misunderstanding the Market’s Potential
6.5 Structural Inequities in Funding and Reimbursement
6.6 The VC’s Macro Existential Crisis and Women’s Health
6.7 Toward an Inclusive Future for Women’s Health
6.8 References
7. Conclusion: What Future Awaits My Daughters?
Continue reading at sergeiAI.substack.com...
Digital Health Leader | Nurse + Informaticist | Implementation Science in Action | FHIR, CMS, Epic, AI | Strategy → Execution
4 个月#TheStruggleIsReal
Business Analyst
4 个月Insightful
#AAM #AI #TechHartford | MSc MBA MA (Econ)
4 个月Learned from this situation while mentoring a brilliant Ivy-league founder with her 'femtech' venture a few years ago: The gender asymmetry in funding contributes to health disparities. Women startups received < 3% funding* and 'FemTech' health market is important for women's healthcare interventions. Fewer investments cause delayed or absence of innovation - leading to health disparities for women. *Women-Led Startups Received Just 2.3% of VC Funding in 2020 | @HarvardBiz 2/25/2021 https://hbr.org/2021/02/women-led-startups-received-just-2-3-of-vc-funding-in-2020
Personalized AppBinder | Nostalgic Writing Therapy | Traditional Medicine in Chronic Care
4 个月In support of the 2024 Executive Order on Advancing Women’s Health Research and Innovation and the NIH-Wide Strategic Plan for Research on the Health of Women 2024-2028, ORWH would like to engage scientific societies to provide names of investigators who have an expertise in and an appreciation for research relevant to women’s health but have not yet had an opportunity to serve on a study section. Investigators who would be excellent candidates for peer review should have an expertise in a) diseases or conditions that are female-specific or primarily affect women or b) diseases or conditions where the prevalence, courses, trajectories, mechanisms, or outcomes are different in women as compared to men. Peer reviewers who also understand the socioecological influences among women and other populations experiencing disparities would be important to this effort. The Center for Scientific Review (CSR) reviews three quarters of all NIH applications and virtually all submitted R01s. Assisting CSR in identifying reviewers with expertise in women’s health will have a broad impact by ensuring the development of a more comprehensive knowledge base on diseases and disorders that affect women.
Board Member, Adjunct Professor, Healthcare Optimist ?
4 个月Appreciate you covering this topic in such depth! Now let’s get to work.